
|Videos|March 3, 2023
Considerations For ADT Selection And Patient Education on Treatment-Related AEs
Expert insight on selection of androgen deprivation therapy and how related adverse events may be communicated to patients in advance.
Advertisement
Episodes in this series

January 2023 AbbVie Inc. Company Confidential
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants fast track designation to Enolen for localized prostate cancer
2
Pivotal trial of Butterfly Device for BPH reaches final completion
3
Genomic classifier score linked with focal therapy outcomes in prostate cancer
4
What’s new at Urology on the Beach 2026
5



























